New rounds

Labquality is actively following the development of laboratory medicine and we want to produce clinically relevant EQA schemes to serve clinical laboratories and point-of-care sites. We launch new pilots studies on a regular basis and aim to increase our EQA portfolio with 5-10 new EQA schemes every year.

 


 

Planned pilot studies for 2022


Labquality is planning new EQA pilot studies for 2022. The pilot rounds will be free of charge for a limited number of participants. It is possible to register to one or several pilots of the selection below by using this link through which we also ask for some additional information regarding your test methods. This registration form will close on January 30th, 2022. More information regarding the specific pilot rounds will be provided to the registered participants when schedules have been decided. Your organization may fill in the form either separately for different pilots or register all at once. Both options are equally good and we are looking forward to having several laboratories from different countries taking part in the pilot studies.

 

 

Clinical chemistry: ACTH, Adrenocorticotropic hormone
Clinical chemistry:
Haemoblobin and Haematocrit for POCT
Clinical chemistry:
Cortisol of saliva
Immunology: 
Chemokine CXCL13, biomarker for neuroborreliosis 
Microbiology:
Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection

 

Microbiology: Quantiferon/IGRA – Interferon gamma releasing assay for tuberculosis diagnostics
Microbiology: Blood culture pathogens (sepsis), multiplex, nucleic acid detection
Virology: West Nile virus, antibody detection
Mycology: Fungal infection, direct nucleic acid detection
Mycology: Fungal infection, native and fluorescence virtual microscopy
Parasitology: Leishmania, nucleic acid detection or antibody detection

 


 

Pilot study: Preanalytics, Pneumatic Sample Transport

Labquality is announcing a new EQA scheme for Preanalytics of Pneumatic Sample Transport. Round 1 will be a pilot study free of charge for a limited number of participants. Round 2, 2021 in October will be chargeable offering measurements of up to three transport lines. Registration includes participation in both rounds.
Registration for the pilot study is closed. Please check the product catalogue for the schedules of 2022 rounds.

Pilot study: Interleukin-6

New EQA scheme for Interleukin-6 (IL-6). IL-6 is one of the major cytokines associated with Covid-19 induced cytokine storm. With the Covid-19 pandemic, there has been an increasing request for IL-6 EQA, which Labquality is proud to fulfil with this new EQA scheme.
Registration for the pilot study is closed. Please check the product catalogue for the schedules of 2022 rounds.

Pilot round: Ketones (beta-hydroxybutyrate)

New EQA scheme for ketones (beta-hydroxybutyrate). Beta-hydroxybutyrate, also know as 3-hydroxybutyrate, is the most abundant of ketones produced during either diabetic ketoacidosis or ketosis.
Registration for the pilot study is closed. Please check the product catalogue for the schedules of 2022 rounds.

Pin It on Pinterest

Share This